NCT01825590

Brief Summary

A difference between dialysate and serum sodium concentration leads to diffusive sodium transfer across the dialyzer membrane. The consequences of diffusive sodium flux into the patient can be chronic sodium overload leading to overhydration, hypertension, cardiovascular disease, and other problems. Diffusive sodium flux out of the patient can lead to intradialytic blood pressure instability. A simple strategy for alignment of dialysate and serum sodium concentrations was implemented starting in April/May 2010 in order to minimize the problems particularly associated with chronic sodium overload.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 13, 2013

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 5, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

February 24, 2016

Status Verified

February 1, 2016

Enrollment Period

3.3 years

First QC Date

March 13, 2013

Last Update Submit

February 23, 2016

Conditions

Keywords

hemodialysisdialysate and serum sodium

Outcome Measures

Primary Outcomes (2)

  • Interdialytic weight gain

    Each dialysis treatment (3x per week) - 2 years of treatment data

  • Pre-dialysis Blood Pressure

    Each dialysis treatment (3x per week)- 2 years of treatment data

Secondary Outcomes (1)

  • Hospitalization rate and number of days

    Per occurence during the entire follow-up period of 2 years

Other Outcomes (6)

  • Body weight

    Each treatment (3x per week)- 2 years of treatment data

  • Serum electrolytes

    Each treatment (3x per week)- 2 years of treatment data

  • Intradialytic saline administration

    Per occurance

  • +3 more other outcomes

Study Arms (2)

Subjects undergoing sodium alignment

Dialysate and serum sodium concentration aligned

Other: Dialysate and serum sodium concentration aligned

Subjects not undergoing sodium alignment

Dialysate and serum sodium concentration not aligned

Interventions

Subjects undergoing sodium alignment

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All subjects on hemodialysis

You may qualify if:

  • Subjects on hemodialysis

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renal Research Institute

New York, New York, 10128, United States

Location

Related Publications (1)

  • Raimann JG, Ficociello LH, Usvyat LA, Zhang H, Pacelli L, Moore S, Sheppard P, Xiao Q, Wang Y, Mullon C, Balter P, Sullivan T, Kotanko P. Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project. BMC Nephrol. 2018 Apr 2;19(1):75. doi: 10.1186/s12882-018-0870-0.

MeSH Terms

Interventions

Dialysis Solutions

Intervention Hierarchy (Ancestors)

Pharmaceutical SolutionsSolutionsPharmaceutical PreparationsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesSpecialty Uses of Chemicals

Study Officials

  • Peter Kotanko, MD

    Renal Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2013

First Posted

April 5, 2013

Study Start

May 1, 2011

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

February 24, 2016

Record last verified: 2016-02

Locations